1. Home
  2. MTEM vs ALBT Comparison

MTEM vs ALBT Comparison

Compare MTEM & ALBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MTEM
  • ALBT
  • Stock Information
  • Founded
  • MTEM N/A
  • ALBT 2014
  • Country
  • MTEM United States
  • ALBT United States
  • Employees
  • MTEM N/A
  • ALBT N/A
  • Industry
  • MTEM Biotechnology: Biological Products (No Diagnostic Substances)
  • ALBT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • MTEM Health Care
  • ALBT Health Care
  • Exchange
  • MTEM Nasdaq
  • ALBT Nasdaq
  • Market Cap
  • MTEM 8.5M
  • ALBT 9.5M
  • IPO Year
  • MTEM N/A
  • ALBT N/A
  • Fundamental
  • Price
  • MTEM $1.39
  • ALBT $0.46
  • Analyst Decision
  • MTEM
  • ALBT
  • Analyst Count
  • MTEM 0
  • ALBT 0
  • Target Price
  • MTEM N/A
  • ALBT N/A
  • AVG Volume (30 Days)
  • MTEM 26.6K
  • ALBT 141.5K
  • Earning Date
  • MTEM 08-08-2024
  • ALBT 08-12-2024
  • Dividend Yield
  • MTEM N/A
  • ALBT N/A
  • EPS Growth
  • MTEM N/A
  • ALBT N/A
  • EPS
  • MTEM N/A
  • ALBT N/A
  • Revenue
  • MTEM $31,763,000.00
  • ALBT $959,516.00
  • Revenue This Year
  • MTEM N/A
  • ALBT N/A
  • Revenue Next Year
  • MTEM N/A
  • ALBT N/A
  • P/E Ratio
  • MTEM N/A
  • ALBT N/A
  • Revenue Growth
  • MTEM N/A
  • ALBT 6.08
  • 52 Week Low
  • MTEM $1.01
  • ALBT $0.24
  • 52 Week High
  • MTEM $9.45
  • ALBT $1.70
  • Technical
  • Relative Strength Index (RSI)
  • MTEM 58.58
  • ALBT 49.46
  • Support Level
  • MTEM $1.27
  • ALBT $0.45
  • Resistance Level
  • MTEM $1.28
  • ALBT $0.51
  • Average True Range (ATR)
  • MTEM 0.09
  • ALBT 0.05
  • MACD
  • MTEM 0.04
  • ALBT -0.01
  • Stochastic Oscillator
  • MTEM 94.74
  • ALBT 36.46

About MTEM Molecular Templates Inc.

Molecular Templates Inc is a clinical-stage biopharmaceutical company focused on developing therapeutic agents that selectively target tumor cells for the treatment of individuals living with cancer. Its pipeline products are MT-6402, MT-8421 and MT-0169.

About ALBT Avalon GloboCare Corp.

Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment which is the key revenue driver; medical-related consulting services segment. It focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.

Share on Social Networks: